交易 GlycoMimetics - GLYC CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
| 價差 | 0.0180 | ||||||||
|
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
|
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
| 隔夜費時間 | 21:00 (UTC) | ||||||||
| 最小成交量 | 1 | ||||||||
| 貨幣 | USD | ||||||||
| 保證金 | 5% | ||||||||
| 股票交易 | United States of America | ||||||||
| 交易委員會 | 0% |
*Information provided by Capital.com
GlycoMimetics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
| 日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 2.1460 | -0.1400 | -6.12% | 2.2860 | 2.2960 | 2.1460 |
| Apr 17, 2024 | 2.2760 | 0.1500 | 7.06% | 2.1260 | 2.3760 | 2.1260 |
| Apr 16, 2024 | 2.1460 | -0.0900 | -4.03% | 2.2360 | 2.3060 | 2.1360 |
| Apr 15, 2024 | 2.2460 | -0.1500 | -6.26% | 2.3960 | 2.4460 | 2.2260 |
| Apr 12, 2024 | 2.3760 | -0.1100 | -4.42% | 2.4860 | 2.5160 | 2.3060 |
| Apr 11, 2024 | 2.4960 | 0.0000 | 0.00% | 2.4960 | 2.5260 | 2.4760 |
| Apr 10, 2024 | 2.4360 | -0.2400 | -8.97% | 2.6760 | 2.6760 | 2.4160 |
| Apr 9, 2024 | 2.6660 | 0.0600 | 2.30% | 2.6060 | 2.6960 | 2.5860 |
| Apr 8, 2024 | 2.5760 | -0.2100 | -7.54% | 2.7860 | 2.7860 | 2.5560 |
| Apr 5, 2024 | 2.7360 | -0.0700 | -2.49% | 2.8060 | 2.8060 | 2.6460 |
| Apr 4, 2024 | 2.6960 | -0.0800 | -2.88% | 2.7760 | 2.8460 | 2.6760 |
| Apr 3, 2024 | 2.7560 | -0.2100 | -7.08% | 2.9660 | 2.9960 | 2.7160 |
| Apr 2, 2024 | 2.9460 | -0.0500 | -1.67% | 2.9960 | 3.1260 | 2.8960 |
| Apr 1, 2024 | 3.0260 | 0.0100 | 0.33% | 3.0160 | 3.1060 | 2.9860 |
| Mar 28, 2024 | 3.0060 | -0.0400 | -1.31% | 3.0460 | 3.0760 | 2.8960 |
| Mar 27, 2024 | 3.1560 | 0.2600 | 8.98% | 2.8960 | 3.1560 | 2.7460 |
| Mar 26, 2024 | 2.8460 | 0.0000 | 0.00% | 2.8460 | 2.8760 | 2.7760 |
| Mar 25, 2024 | 2.8260 | -0.1000 | -3.42% | 2.9260 | 3.0060 | 2.7660 |
| Mar 22, 2024 | 2.9360 | 0.1400 | 5.01% | 2.7960 | 2.9960 | 2.7860 |
| Mar 21, 2024 | 2.8760 | 0.0300 | 1.05% | 2.8460 | 3.1060 | 2.8360 |
GlycoMimetics Events
| 時間 (UTC) | 國家 | 事件 |
|---|---|---|
| Wednesday, May 1, 2024 | ||
| 時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 GlycoMimetics Inc Earnings Release Q1 2024 GlycoMimetics Inc Earnings ReleaseForecast（預報） -返回 - |
| 時間 (UTC) 13:00 | 國家 US
| 事件 GlycoMimetics Inc Annual Shareholders Meeting GlycoMimetics Inc Annual Shareholders MeetingForecast（預報） -返回 - |
| Friday, May 17, 2024 | ||
| 時間 (UTC) 13:00 | 國家 US
| 事件 GlycoMimetics Inc Annual Shareholders Meeting GlycoMimetics Inc Annual Shareholders MeetingForecast（預報） -返回 - |
| Wednesday, July 31, 2024 | ||
| 時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 GlycoMimetics Inc Earnings Release Q2 2024 GlycoMimetics Inc Earnings ReleaseForecast（預報） -返回 - |
- 每年
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 總收入 | 0.075 | 1.15977 | 10.1629 | 0 | 0 |
| 收入 | 0.075 | 1.15977 | 10.1629 | 0 | 0 |
| 總營業費用 | 47.4783 | 64.607 | 61.6723 | 61.3893 | 51.5048 |
| 銷售/一般/行政費用，總計 | 19.0874 | 17.1154 | 16.7431 | 14.36 | 11.413 |
| 研究與開發 | 28.3909 | 47.4916 | 44.9292 | 47.0293 | 40.0918 |
| 營業收入 | -47.4033 | -63.4472 | -51.5094 | -61.3893 | -51.5048 |
| 利息收入（費用），非經營淨值 | 0.71452 | 0.01977 | 0.48249 | 3.49739 | 3.23119 |
| 稅前淨收入 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 稅後淨收入 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 未計算非常項目前的淨收益 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 淨收入 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 普通股股東可獲收益 (不含非經常性項目) | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 普通股股東可獲收益 (含非經常性項目) | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 攤薄淨收入 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 攤薄後加權平均股 | 52.5312 | 51.4532 | 45.7211 | 43.2548 | 41.0446 |
| 扣除特別項目的每股攤薄盈利 | -0.88878 | -1.23272 | -1.11605 | -1.33839 | -1.17613 |
| 每股正常攤薄盈利 | -0.88878 | -1.23272 | -1.11605 | -1.33839 | -1.17613 |
| 非常規項目總計 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| 總收入 | 0 | 0 | 0 | 0 | 0.075 |
| 收入 | 0 | 0 | 0 | 0.075 | |
| 總營業費用 | 8.92995 | 10.941 | 10.6226 | 8.76744 | 13.4282 |
| 銷售/一般/行政費用，總計 | 4.85724 | 5.52231 | 4.7318 | 3.84458 | 5.45488 |
| 研究與開發 | 4.07271 | 5.41871 | 5.89082 | 4.92286 | 7.97328 |
| 營業收入 | -8.92995 | -10.941 | -10.6226 | -8.76744 | -13.3532 |
| 利息收入（費用），非經營淨值 | 0.67103 | 0.58167 | 0.37827 | 0.2436 | 0.08559 |
| 稅前淨收入 | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 稅後淨收入 | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 未計算非常項目前的淨收益 | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 淨收入 | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 普通股股東可獲收益 (不含非經常性項目) | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 普通股股東可獲收益 (含非經常性項目) | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 攤薄淨收入 | -8.25891 | -10.3594 | -10.2444 | -8.52384 | -13.2676 |
| 攤薄後加權平均股 | 64.2762 | 60.3501 | 52.962 | 52.4239 | 52.4073 |
| 扣除特別項目的每股攤薄盈利 | -0.12849 | -0.17165 | -0.19343 | -0.16259 | -0.25316 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| 每股正常攤薄盈利 | -0.12849 | -0.17165 | -0.19343 | -0.16259 | -0.25316 |
- 每年
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 流動資産總額 | 50.7147 | 90.7887 | 138.273 | 162.528 | 212.269 |
| 現金和短期投資 | 47.8706 | 90.2549 | 137.035 | 158.201 | 209.918 |
| 現金等價物 | 47.8706 | 90.2549 | 137.035 | 158.201 | 209.918 |
| 短期投資 | |||||
| 應收賬款總額，淨額 | 0.14402 | 0.00135 | 0.00215 | 0.18595 | 0.41312 |
| 預付的費用 | 2.70007 | 0.53246 | 1.23618 | 4.14037 | 1.9384 |
| 總資産 | 51.8106 | 94.3466 | 142.832 | 167.97 | 214.839 |
| 物業/廠房/設備，總計 - 淨額 | 0.99356 | 1.94503 | 2.9459 | 3.82899 | 0.95723 |
| 物業/廠房/設備，總計 - 總額 | 3.38018 | 4.26792 | 5.0782 | 5.69053 | 2.54087 |
| 累計折舊，總計 | -2.38662 | -2.3229 | -2.1323 | -1.86155 | -1.58364 |
| 其他長期資産，總計 | 0.10232 | 1.61293 | 1.61293 | 1.61293 | 1.61293 |
| 流動負債總額 | 8.88075 | 11.8244 | 12.4284 | 10.9506 | 8.76315 |
| 應付賬款 | 0.97019 | 2.10762 | 2.08994 | 1.43566 | 2.66358 |
| 預提費用 | 7.91056 | 9.71678 | 10.3384 | 9.51492 | 6.0008 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 其他流動負債，總計 | 0.09877 | ||||
| 負債總額 | 8.88075 | 12.743 | 14.6127 | 13.7691 | 9.37478 |
| 長期債務總額 | 0 | 0 | 0 | 0 | 0 |
| 其他負債，總計 | 0 | 0.91861 | 2.18434 | 2.81852 | 0.61162 |
| 股權 | 42.9298 | 81.6037 | 128.219 | 154.201 | 205.464 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
| 普通股 | 0.05438 | 0.05231 | 0.04902 | 0.04347 | 0.04316 |
| 額外實收資本 | 462.461 | 454.448 | 437.64 | 412.6 | 405.972 |
| 留存收益（累計赤字） | -419.586 | -372.897 | -309.47 | -258.443 | -200.551 |
| 總負債和股東權益 | 51.8106 | 94.3466 | 142.832 | 167.97 | 214.839 |
| 已發行普通股總數 | 54.3778 | 52.3139 | 49.0176 | 43.4669 | 43.1608 |
| Total Preferred Shares Outstanding |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| 流動資産總額 | 52.0101 | 60.3688 | 68.0865 | 50.7147 | 53.8482 |
| 現金和短期投資 | 49.4076 | 58.0371 | 65.0023 | 47.8706 | 51.6248 |
| 現金等價物 | 49.4076 | 58.0371 | 65.0023 | 47.8706 | 51.6248 |
| 應收賬款總額，淨額 | 0.18895 | 0.21537 | 0.23411 | 0.14402 | 0.09033 |
| 預付的費用 | 2.4135 | 2.11639 | 2.85008 | 2.70007 | 2.13309 |
| 總資産 | 53.2007 | 61.8215 | 68.9217 | 51.8106 | 55.9614 |
| 物業/廠房/設備，總計 - 淨額 | 1.08829 | 1.35036 | 0.7328 | 0.99356 | 1.25313 |
| 物業/廠房/設備，總計 - 總額 | 3.59843 | 3.81775 | 3.16326 | 3.38018 | 3.59403 |
| 累計折舊，總計 | -2.51014 | -2.46739 | -2.43045 | -2.38662 | -2.3409 |
| 其他長期資産，總計 | 0.10232 | 0.10232 | 0.10232 | 0.10232 | 0.86012 |
| 流動負債總額 | 6.39088 | 6.572 | 6.74021 | 8.88075 | 7.74825 |
| 應付賬款 | 0.32989 | 0.24149 | 0.48015 | 0.97019 | 0.85213 |
| 預提費用 | 6.061 | 6.33052 | 6.26006 | 7.91056 | 6.89613 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 負債總額 | 6.65301 | 7.02078 | 6.74021 | 8.88075 | 7.84386 |
| 長期債務總額 | 0 | 0 | 0 | 0 | 0 |
| 其他負債，總計 | 0.26213 | 0.44878 | 0 | 0.09561 | |
| 股權 | 46.5477 | 54.8007 | 62.1814 | 42.9298 | 48.1176 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| 普通股 | 0.06437 | 0.06431 | 0.06425 | 0.05438 | 0.05242 |
| 額外實收資本 | 493.89 | 492.94 | 492.062 | 462.461 | 457.407 |
| 留存收益（累計赤字） | -447.407 | -438.204 | -429.945 | -419.586 | -409.341 |
| 總負債和股東權益 | 53.2007 | 61.8215 | 68.9217 | 51.8106 | 55.9614 |
| 已發行普通股總數 | 64.3688 | 64.3133 | 64.2452 | 54.3778 | 52.4239 |
- 每年
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 淨收入/起跑線 | -46.6888 | -63.4274 | -51.0269 | -57.8919 | -48.2736 |
| 經營活動産生的現金 | -46.4575 | -57.4895 | -39.2419 | -51.9841 | -43.3311 |
| 經營活動産生的現金 | 0.20715 | 0.2646 | 0.27075 | 0.27923 | 0.27512 |
| 非現金物品 | 4.68609 | 6.8385 | 7.5826 | 6.83516 | 4.58727 |
| Cash Taxes Paid | |||||
| 營運資金的變化 | -4.66192 | -1.16519 | 3.93162 | -1.20662 | 0.08011 |
| 投資活動産生的現金 | -0.08419 | -0.01494 | -0.06851 | -0.14493 | -0.12562 |
| 資本支出 | -0.08419 | -0.01494 | -0.06851 | -0.14493 | -0.12562 |
| 融資活動産生的現金 | 4.15741 | 10.7243 | 18.144 | 0.41291 | 129.45 |
| 股票的發行（報廢），淨額 | 4.15741 | 10.7243 | 18.144 | 0.41291 | 129.45 |
| 現金淨變化 | -42.3843 | -46.7801 | -21.1664 | -51.7161 | 85.9929 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -10.3594 | -46.6888 | -36.4445 | -27.9206 | -14.653 |
| Cash From Operating Activities | -11.6069 | -46.4575 | -38.5459 | -29.9288 | -13.6981 |
| Cash From Operating Activities | 0.04384 | 0.20715 | 0.16143 | 0.11408 | 0.05931 |
| Non-Cash Items | 1.0893 | 4.68609 | 3.57304 | 2.45038 | 1.27946 |
| Changes in Working Capital | -2.38065 | -4.66192 | -5.83594 | -4.57266 | -0.38387 |
| Cash From Investing Activities | -0.0022 | -0.08419 | -0.08419 | -0.08171 | -0.04052 |
| Capital Expenditures | -0.0022 | -0.08419 | -0.08419 | -0.08171 | -0.04052 |
| Cash From Financing Activities | 28.7408 | 4.15741 | 0 | 0 | 0 |
| Issuance (Retirement) of Stock, Net | 28.7408 | 4.15741 | 0 | 0 | 0 |
| Net Change in Cash | 17.1317 | -42.3843 | -38.6301 | -30.0105 | -13.7387 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模（槓桿 x 投資）：
打開
拋售
已賣出 做多
| Industry: | Bio Therapeutic Drugs |
9708 Medical Center Drive
ROCKVILLE
MARYLAND 20850
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商？
加入全球 610,000 多名交易者，選擇與 Capital.com 交易